Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.61 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | POLA1 | P09884 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PNP | P00491 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37384 | 0.79 | DPP4 (0.66) | DPP4XDHPDPK1GDAADORA3 | |
| SCHEMBL533603 | 0.79 | PDPK1 (0.44) | DPP4XDHPDPK1GDAADORA3 | |
| SCHEMBL8719273 | 0.78 | DPP4 (0.63) | DPP4XDHPDPK1GDAADORA3 | |
| Hydrochloric Acid SCHEMBL4763244 | 0.78 | DPP4 (0.63) | DPP4XDHPDPK1GDAADORA3 | |
| SCHEMBL11456967 | 0.78 | DPP4 (0.63) | DPP4XDHPDPK1GDAADORA3 | |
| SCHEMBL612211 | 0.76 | GDA (0.41) | DPP4XDHPDPK1GDAADORA3 | |
| SCHEMBL497199 | 0.76 | PDPK1 (0.66) | DPP4XDHPDPK1GDAPOLA1 | |
| SCHEMBL16146853 | 0.76 | PDPK1 (0.41) | DPP4XDHPDPK1GDAADORA3 | |
| SCHEMBL5145886 | 0.76 | CDK2 (0.61) | DPP4XDHPDPK1GDAADORA3 | |
| SCHEMBL29873925 | 0.76 | PDPK1 (0.66) | DPP4XDHPDPK1GDAPOLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023063168-A1 | PEST CONTROLLING COMPOSITION | ダイキン工業株式会社 | 2023-04-20 | — | — | WO | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| EP-3340982-B1 | COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS INC (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3340982-B1 | COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS INC (US) | 2021-12-15 | — | — | EP | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-10807952-B2 | Compounds for treatment of immune inflammatory disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2020-10-20 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| CN-1314685-C | Process for preparing 2, 6-dihalogenopurine | SUMITOMO CHEMICAL CO (JP) | 2007-05-09 | — | — | CN | disclosed |
| US-20070032645-A1 | Method for the preparation of 2-halo-2'-deoxyadenosine compounds for 2'-deoxyguanosine | BRIGHAM YOUNG UNIVERSITY (US) | 2007-02-08 | — | — | US | disclosed |
| EP-1556400-A2 | METHOD FOR THE PREPARATION OF 2-HALO-2 -DEOXYADENOSINE COMPOUNDS FROM 2 -DEOXYGUANOSINE | Brigham Young University (US) | 2005-07-27 | — | — | EP | disclosed |
| CN-1646532-A | Process for preparing 2, 6-dihalogenopurine | SUMITOMO CHEMICAL CO (JP) | 2005-07-27 | — | — | CN | disclosed |
| US-20050131229-A1 | Production method of 2,6-dihalopurine | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-06-16 | — | — | US | disclosed |
| EP-1490369-A1 | PRODUCTION METHOD OF 2,6-DIHALOPURINE | Sumitomo Chemical Company, Limited (JP) | 2004-12-29 | — | — | EP | disclosed |
| WO-2004028462-A2 | METHOD FOR THE PREPARATION OF 2-HALO-2'-DEOXYADENOSINE COMPOUNDS FROM 2'-DEOXYGUANOSINE | BRIGHAM YOUNG UNIVERSITY, TECHNOLOGY TRANSFER OFFICE (US) | 2004-04-08 | — | — | WO | disclosed |
| WO-2003084958-A1 | PRODUCTION METHOD OF 2,6-DIHALOPURINE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-10-16 | — | — | WO | disclosed |
| US-4617189-A | Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine | STOCKEL RICHARD F (US) | 1986-10-14 | — | — | US | disclosed |
| US-4536571-A | SEFL-DETOXIFYING ANTICARCINOGENIC AGENT | STOCKEL RICHARD F (US) | 1985-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10807952-B2 | Compounds for treatment of immune inflammatory disorders | CFD, TFPI, CFH | DPP4 2552/4885XDH 910/4885PDPK1 1063/4885 |
| US-20070032645-A1 | Method for the preparation of 2-halo-2'-deoxyadenosine compounds for 2'-deoxyguanosine | DCTD, CDA, UNG | DPP4 3564/4885XDH 810/4885PDPK1 4526/4885 |
| US-20050131229-A1 | Production method of 2,6-dihalopurine | TPMT, DHPS, DUS2 | DPP4 1057/4885XDH 409/4885PDPK1 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.